Evaluating cancer screening programs using survival analysis
From MaRDI portal
Publication:6572294
DOI10.1002/BIMJ.202200344zbMATH Open1541.62325MaRDI QIDQ6572294
Maja Pohar Perme, Bor Vratanar
Publication date: 15 July 2024
Published in: Biometrical Journal (Search for Journal in Brave)
Cites Work
- Instrumental variable estimation of early treatment effect in randomized screening trials
- A unifying framework for continuous tumour growth modelling of breast cancer screening data
- Statistical models of tumour onset and growth for modern breast cancer screening cohorts
- Nonparametric Estimation from Incomplete Observations
- A Stochastic Model for Calibrating the Survival Benefit of Screen-Detected Cancers
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
- Formulating causal questions and principled statistical answers
This page was built for publication: Evaluating cancer screening programs using survival analysis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6572294)